Medium-grade proteinuria is a risk factor for incident markers of chronic kidney disease

S Y Schrader1,2, A J Zeder1,3, R Hilge1,4

  • 1Sektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, München, Germany.

HIV Medicine
|June 20, 2020
PubMed
Abstract

Insights

Medium-grade proteinuria is common in people living with HIV/AIDS (PLWHA) and significantly increases their risk for chronic kidney disease (CKD). Lower detection thresholds for proteinuria are needed to identify at-risk PLWHA for early intervention.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • Medium-grade proteinuria (100-500 mg/g creatinine) is prevalent in people living with HIV/AIDS (PLWHA) but often overlooked.
  • This condition is a potential risk factor for developing chronic kidney disease (CKD).

Purpose of the Study:

  • To investigate medium-grade proteinuria as a risk factor for incident markers of CKD in PLWHA.
  • To evaluate the association between proteinuria levels and the development of CKD markers.

Main Methods:

  • A prospective, observational cohort study involving 241 PLWHA without prior renal disease.
  • Quantitative urine samples collected at baseline and 240 weeks later.
  • Multivariate analysis to assess risk factors for CKD markers (eGFR < 60 mL/min/1.73 m², albuminuria, phosphaturia).

Main Results:

  • 14% of participants developed incident CKD markers, with 74% having baseline medium-grade proteinuria.
  • An adjusted relative risk (aRR) of 2.4 for developing CKD markers was observed in patients with baseline medium-grade proteinuria.
  • Proteinuria independent of tenofovir disoproxil fumarate (TDF) showed a strong association with incident CKD markers (aRR = 12.1).

Conclusions:

  • Medium-grade proteinuria (100-500 mg/g creatinine) is a frequent and significant risk factor for CKD in PLWHA.
  • Risk is evident even at lower proteinuria levels (100-200 mg/g creatinine), particularly when TDF is not a factor.
  • Current guidelines may miss at-risk individuals; a lower proteinuria threshold for nephrological evaluation is recommended.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
446
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
131
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
277
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
444
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
386
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
335